Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mannebach

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Experimental studies on hyperlactacidemia: limiting values of lactate utilization during acute and protracted pyruvate load]H Mannebach, T Treydte, B Hoffsümmer, et al.
Die Rehabilitation|October 11, 2002
[Women and men after acute myocardial infarction: are there gender differences in participation rates in cardiac rehabilitation?]G Grande, A Leppin, M Romppel, et al.
Thrombosis and Haemostasis|May 29, 1999
The prevalence of the prothrombin 20210 G-->A mutation is not increased in angiographically confirmed coronary artery diseaseW Prohaska, M Schmidt, H Mannebach, et al.
Versicherungsmedizin|April 1, 1995
[Clinical significance of the cardiovascular risk factor fibrinogen in secondary prevention]D Baller, U Gleichmann, E Miche, et al.
Herz|December 22, 1998
[Diagnosis and differential therapy of mitral stenosis]D Fassbender, H K Schmidt, H Seggewiss, et al.
Zeitschrift Fur Kardiologie|January 1, 1986
[Long term therapy of coronary heart disease with 120 mg slow release isosorbide dinitrate once a day. Study of duration of action and development of tolerance]H Ohlmeier, H M Mertens, M Möller, et al.
Die Medizinische Welt|April 7, 1981
[Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease]H Mannebach, H Ohlmeier, E von Möllendorff, et al.
Herz|June 1, 1985
[4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment]H M Mertens, H Ohlmeier, H Mannebach, et al.
International Journal of Technology Assessment in Health Care|January 25, 2000
Cardiac catheterization in Germany. Diffusion and utilization from 1984 to 1996M Perleth, H Mannebach, R Busse, et al.
Zeitschrift Fur Kardiologie|October 1, 1979
[Long-term treatment of bradycardia by means of an atropine ester (SCH 1000). Electrophysiological and clinical results]G Trieb, H M Mertens, I Bistreanu, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Experimental studies on hyperlactacidemia: limiting values of lactate utilization during acute and protracted pyruvate load]H Mannebach, T Treydte, B Hoffsümmer, et al.
Die Rehabilitation|October 11, 2002
[Women and men after acute myocardial infarction: are there gender differences in participation rates in cardiac rehabilitation?]G Grande, A Leppin, M Romppel, et al.
Thrombosis and Haemostasis|May 29, 1999
The prevalence of the prothrombin 20210 G-->A mutation is not increased in angiographically confirmed coronary artery diseaseW Prohaska, M Schmidt, H Mannebach, et al.
Versicherungsmedizin|April 1, 1995
[Clinical significance of the cardiovascular risk factor fibrinogen in secondary prevention]D Baller, U Gleichmann, E Miche, et al.
Herz|December 22, 1998
[Diagnosis and differential therapy of mitral stenosis]D Fassbender, H K Schmidt, H Seggewiss, et al.
Zeitschrift Fur Kardiologie|January 1, 1986
[Long term therapy of coronary heart disease with 120 mg slow release isosorbide dinitrate once a day. Study of duration of action and development of tolerance]H Ohlmeier, H M Mertens, M Möller, et al.
Die Medizinische Welt|April 7, 1981
[Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease]H Mannebach, H Ohlmeier, E von Möllendorff, et al.
Herz|June 1, 1985
[4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment]H M Mertens, H Ohlmeier, H Mannebach, et al.
International Journal of Technology Assessment in Health Care|January 25, 2000
Cardiac catheterization in Germany. Diffusion and utilization from 1984 to 1996M Perleth, H Mannebach, R Busse, et al.
Zeitschrift Fur Kardiologie|October 1, 1979
[Long-term treatment of bradycardia by means of an atropine ester (SCH 1000). Electrophysiological and clinical results]G Trieb, H M Mertens, I Bistreanu, et al.
Pageof 8